GSK inks 2nd neuro pact in weeks, this time with Danish biotech Muna in Alzheimer's

GSK has penned another neuroscience pact, this time with Danish biotech Muna Therapeutics. The two companies will examine postmortem human brains in efforts to identify several new drug targets for Alzheimer’s disease.